Literature DB >> 20842026

Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.

Hannele Yki-Järvinen1.   

Abstract

PURPOSE OF REVIEW: Concomitant with the obesity epidemic, a fatty liver due to nonalcoholic causes has become the most common liver disorder. Nonalcoholic fatty liver disease (NAFLD) covers a range from benign steatosis to nonalcoholic steatohepatitis (NASH), which in turn may progress to cirrhosis. NAFLD predicts, independent of obesity, the metabolic syndrome and type 2 diabetes and can progress to cirrhosis. This review focuses on studies in humans addressing effects of dietary changes in NAFLD. RECENT
FINDINGS: Cross-sectionally, increased intake of fructose and simple sugars characterizes patients with NAFLD compared with weight-matched controls. Increased fructose intake is also associated with hepatic insulin resistance and fibrosis severity in NASH. Intake of saturated fat may also be increased in NAFLD. Dietary intervention studies have shown that liver volume and fat content changes significantly within a few days in response to caloric restriction or excess despite no or small changes in body weight. Weight loss by bariatric surgery decreases liver fat and inflammation but effects on fibrosis are uncertain. Hepatic insulin sensitivity generally changes in parallel with changes in liver fat content in NAFLD. Human data are limited regarding effects of isocaloric changes in diet composition on liver fat content.
SUMMARY: Maintenance of normal body weight and avoidance of intake of excess lipogenic simple sugars would seem beneficial for prevention of NAFLD and its metabolic consequences.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20842026     DOI: 10.1097/MCO.0b013e32833f4b34

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  22 in total

1.  Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose.

Authors:  Raffaella Crescenzo; Francesca Bianco; Italia Falcone; Paola Coppola; Giovanna Liverini; Susanna Iossa
Journal:  Eur J Nutr       Date:  2012-04-28       Impact factor: 5.614

2.  Experimental models of non-alcoholic fatty liver disease in rats.

Authors:  Otto Kucera; Zuzana Cervinkova
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

3.  Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis.

Authors:  Karen D Corbin; Manal F Abdelmalek; Melanie D Spencer; Kerry-Ann da Costa; Joseph A Galanko; Wei Sha; Ayako Suzuki; Cynthia D Guy; Diana M Cardona; Alfonso Torquati; Anna Mae Diehl; Steven H Zeisel
Journal:  FASEB J       Date:  2013-01-04       Impact factor: 5.191

4.  Exotic Fruits as Therapeutic Complements for Diabetes, Obesity and Metabolic Syndrome.

Authors:  Samir Devalaraja; Shalini Jain; Hariom Yadav
Journal:  Food Res Int       Date:  2011-08-01       Impact factor: 6.475

5.  Nutritional recommendations for patients with non-alcoholic fatty liver diseases.

Authors:  Nimer Assy
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

6.  Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2.

Authors:  François R Jornayvaz; Andreas L Birkenfeld; Michael J Jurczak; Shoichi Kanda; Blas A Guigni; Debbie C Jiang; Dongyan Zhang; Hui-Young Lee; Varman T Samuel; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

Review 7.  Toward a unifying hypothesis of metabolic syndrome.

Authors:  Andrew A Bremer; Michele Mietus-Snyder; Robert H Lustig
Journal:  Pediatrics       Date:  2012-02-20       Impact factor: 7.124

8.  Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes.

Authors:  Donald J Messner; Byung Han Rhieu; Kris V Kowdley
Journal:  Dig Dis Sci       Date:  2013-04-05       Impact factor: 3.199

9.  Measuring short-term liver metabolism non-invasively: postprandial and post-exercise ¹H and ³¹P MR spectroscopy.

Authors:  Antti Hakkarainen; Jesper Lundbom; Esa K Tuominen; Marja-Riitta Taskinen; Kirsi H Pietiläinen; Nina Lundbom
Journal:  MAGMA       Date:  2014-06-04       Impact factor: 2.310

10.  Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats.

Authors:  Kosuke Tanaka; Yuko Masaki; Masatake Tanaka; Masayuki Miyazaki; Munechika Enjoji; Makoto Nakamuta; Masaki Kato; Masatoshi Nomura; Toyoshi Inoguchi; Kazuhiro Kotoh; Ryoichi Takayanagi
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.